Srinivas V Kaveri Selected Research

Srinivas V Kaveri Research Topics

Disease

27	Hemophilia A (Haemophilia) 01/2020 - 11/2002
6	Infections 04/2021 - 04/2005
6	Inflammation (Inflammations) 07/2014 - 04/2005
5	Hemorrhage 01/2020 - 07/2008
4	Neoplasms (Cancer) 04/2021 - 09/2007
4	Sepsis (Septicemia) 07/2010 - 04/2005
3	Communicable Diseases (Infectious Diseases) 04/2021 - 12/2011
3	Thrombosis (Thrombus) 01/2014 - 04/2005
2	Hemorrhagic Disorders (Hemorrhagic Diathesis) 01/2019 - 06/2008
2	Hemolysis 02/2015 - 05/2011
2	Virus Diseases (Viral Diseases) 12/2010 - 07/2009
1	COVID-19 04/2021
1	Diphtheria 04/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020
1	Tuberculosis (Tuberculoses) 01/2016
1	Lymphoma (Lymphomas) 07/2014
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 07/2014
1	Obesity 06/2014
1	Type 2 Diabetes Mellitus (MODY) 06/2014
1	Coinfection 01/2013
1	Septic Shock (Toxic Shock Syndrome) 07/2010
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 04/2010
1	Autoimmune Diseases (Autoimmune Disease) 10/2009
1	HIV Infections (HIV Infection) 05/2008
1	Pathologic Processes 09/2007
1	Ischemia 06/2006
1	Asthma (Bronchial Asthma) 11/2002
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 11/2002
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2002

Drug/Important Bio-Agent (IBA)

25	Factor VIII (Coagulation Factor VIII)IBA 01/2020 - 11/2002
17	AntibodiesIBA 04/2021 - 11/2002
13	Immunoglobulin G (IgG)IBA 01/2020 - 11/2002
8	AntigensIBA 01/2020 - 01/2006
5	Immunoglobulins (Immunoglobulin)IBA 02/2015 - 01/2006
4	Heme (Haem)IBA 02/2015 - 09/2007
3	VaccinesIBA 04/2021 - 07/2009
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2007
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2013 - 04/2010
3	AutoantibodiesIBA 01/2012 - 06/2008
2	von Willebrand FactorIBA 01/2019 - 10/2007
2	Neutralizing AntibodiesIBA 01/2018 - 12/2009
2	CytokinesIBA 06/2014 - 10/2009
2	IsoantibodiesIBA 08/2009 - 06/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2008 - 01/2006
2	Catalytic AntibodiesIBA 04/2005 - 11/2002
1	prothrombin complex concentrates (PPSB)IBA 01/2020
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2020
1	Anti-Idiotypic AntibodiesIBA 01/2020
1	AntithrombinsIBA 01/2020
1	Factor X (Stuart Factor)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Mannose (D-Mannose)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	Protein CIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	SerpinsIBA 01/2020
1	Factor VIIa (Activated Factor VII)IBA 01/2020
1	Factor IXa (Coagulation Factor IXa)IBA 01/2020
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2020
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2020
1	CoagulantsIBA 01/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2019
1	Cysteine (L-Cysteine)FDA Link 01/2018
1	cobra venom factorIBA 01/2018
1	AnaphylatoxinsIBA 01/2018
1	Complement C3 (C3 Complement)IBA 01/2018
1	Dinoprostone (PGE2)FDA Link 04/2016
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2016
1	Immunodominant EpitopesIBA 02/2015
1	AutoantigensIBA 07/2014
1	Interleukin-22 (IL-22)IBA 06/2014
1	Glucose (Dextrose)FDA LinkGeneric 06/2014
1	Complement System Proteins (Complement)IBA 01/2014
1	EnzymesIBA 10/2013
1	Heme Oxygenase-1IBA 10/2013
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 02/2011
1	LipopolysaccharidesIBA 07/2010
1	BuffersIBA 07/2010
1	Hemostatics (Antihemorrhagics)IBA 07/2008
1	Glycoproteins (Glycoprotein)IBA 07/2008
1	Mannose ReceptorIBA 09/2007
1	Ferritins (Ferritin)IBA 01/2006
1	Transferrin (beta 2 Transferrin)IBA 01/2006
1	IonsIBA 01/2006
1	Serine Proteases (Serine Protease)IBA 04/2005
1	Peptide Hydrolases (Proteases)FDA Link 11/2002

Therapy/Procedure

12	Therapeutics 04/2021 - 11/2002
2	Immunotherapy 06/2014 - 07/2009